vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1121Research ArticleЛЕКЦИИLECTURESПНЕВМОКОККОВЫЕ ИНФЕКЦИИ – СНОВА В ЦЕНТРЕ ВНИМАНИЯPNEUMOCOCCAL INFECTION — IN THE CENTRE OF ATTENTION AGAINСидоренкоС.В.SidorenkoS.V.Национальное агентство клинической фармакологии и фармации, МоскваРоссияNational Agency of Clinical Pharmacology and Pharmacy, MoscowRussian Federation20092309201583Вопросы современной педиатрии8287Copyright © Сидоренко С., 20092009Сидоренко С.Sidorenko S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1121ReferencesHarboe Z.B., Thomsen R.W., Riis A. et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population based cohort study. PLoS Med. 2009; 6 (5): е1000081.Harboe Z.B., Thomsen R.W., Riis A. et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population based cohort study. PLoS Med. 2009; 6 (5): е1000081.Regev–Yochay G., Raz M., Dagan R., Porat N., Shainberg B., Pinco E., Keller N., Rubinstein E. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin. Infect. Dis. 2004; 38 (5): 632–639.Regev–Yochay G., Raz M., Dagan R., Porat N., Shainberg B., Pinco E., Keller N., Rubinstein E. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin. Infect. Dis. 2004; 38 (5): 632–639.Syrogiannopoulos GA, Grivea IN, Davies TA, Katopodis GD, Appelbaum PC, Beratis NG. Antimicrobial use and colonization with erythromycin resistant Streptococcus pneumoniae in Greece during the first 2 years of life. Clin. Infect. Dis. 2000; 31 (4): 887–893.Syrogiannopoulos GA, Grivea IN, Davies TA, Katopodis GD, Appelbaum PC, Beratis NG. Antimicrobial use and colonization with erythromycin resistant Streptococcus pneumoniae in Greece during the first 2 years of life. Clin. Infect. Dis. 2000; 31 (4): 887–893.Nunes S., Sa-Leao R., Carrico J. et al. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. J. Clin. Microbiol. 2005; 43 (3): 1285–1293.Nunes S., Sa-Leao R., Carrico J. et al. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. J. Clin. Microbiol. 2005; 43 (3): 1285–1293.Alter SJ. Pneumococcal infections. Pediatr. Rev. 2009; 30 (5): 155–164, quiz 64.Alter SJ. Pneumococcal infections. Pediatr. Rev. 2009; 30 (5): 155–164, quiz 64.Jefferson T., Ferroni E., Curtale F., Giorgi Rossi P., Borgia P. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect. Dis. 2006; 6 (7): 405–410.Jefferson T., Ferroni E., Curtale F., Giorgi Rossi P., Borgia P. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect. Dis. 2006; 6 (7): 405–410.Hsu H.E., Shutt K.A., Moore M.R. et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N. Engl. J. Med. 2009; 360 (3): 244–256.Hsu H.E., Shutt K.A., Moore M.R. et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N. Engl. J. Med. 2009; 360 (3): 244–256.Белошицкий Г.В., Королева И.С., Чистякова Г.Г. Эпидемиологические особенности менингитов, обусловленных S. pneumoniae. Эпидемиология и инфекционные болезни 2005; 3: 28–30.Белошицкий Г.В., Королева И.С., Чистякова Г.Г. Эпидемиологические особенности менингитов, обусловленных S. pneumoniae. Эпидемиология и инфекционные болезни 2005; 3: 28–30.Centers for Disease Control and Prevention, 1999. Доступно на: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/spneu99.pdfCenters for Disease Control and Prevention, 1999. Доступно на: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/spneu99.pdfWhitney C.G., Farley M.M., Hadler J. et al. Decline in invasive pneumococcal disease after the introduction of protein polysaccharide conjugate vaccine. N. Engl. J. Med. 2003; 348 (18): 1737–1746.Whitney C.G., Farley M.M., Hadler J. et al. Decline in invasive pneumococcal disease after the introduction of protein polysaccharide conjugate vaccine. N. Engl. J. Med. 2003; 348 (18): 1737–1746.Centers for Disease Control and Prevention (CDC). Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine United States, 1997-2006. MMWR Morb. Mortal. Wkly Rep. 2009; 58 (1): 1–4.Centers for Disease Control and Prevention (CDC). Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine United States, 1997-2006. MMWR Morb. Mortal. Wkly Rep. 2009; 58 (1): 1–4.Welte T, Kohnlein T. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin Respir. Crit. Care Med. 2009; 30 (2): 127–135.Welte T, Kohnlein T. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin Respir. Crit. Care Med. 2009; 30 (2): 127–135.Schnoor M., Hedicke J., Dalhoff K., Raspe H., Schafer T. Approaches to estimate the population based incidence of community acquired pneumonia. J. Infect. 2007; 55 (3): 233–239.Schnoor M., Hedicke J., Dalhoff K., Raspe H., Schafer T. Approaches to estimate the population based incidence of community acquired pneumonia. J. Infect. 2007; 55 (3): 233–239.Pneumococcal conjugate vaccine for childhood immunization WHO position paper. Wkly Epidemiol. Rec. 2007; 82 (12): 93–104.Pneumococcal conjugate vaccine for childhood immunization WHO position paper. Wkly Epidemiol. Rec. 2007; 82 (12): 93–104.Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction eight states, 1998–2005. MMWR Morb. Mortal. Wkly Rep. 2008; 57 (6): 144–148.Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction eight states, 1998–2005. MMWR Morb. Mortal. Wkly Rep. 2008; 57 (6): 144–148.Grijalva C.G., Nuorti J.P., Arbogast P.G., Martin S.W., Edwards K.M., Griffin M.R. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007; 369 (9568): 1179–1186.Grijalva C.G., Nuorti J.P., Arbogast P.G., Martin S.W., Edwards K.M., Griffin M.R. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007; 369 (9568): 1179–1186.Direct and indirect effects of routine vaccination of children with 7–valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease United States, 1998–2003. MMWR Morb. Mortal. Wkly Rep. 2005; 54 (36): 893–897.Direct and indirect effects of routine vaccination of children with 7–valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease United States, 1998–2003. MMWR Morb. Mortal. Wkly Rep. 2005; 54 (36): 893–897.Tyrrell G.J., Lovgren M., Chui N., Minion J., Garg S., Kellner J.D., Marrie T.J. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre– and post seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006. Vaccine. 2009; 27 (27): 3553–3560.Tyrrell G.J., Lovgren M., Chui N., Minion J., Garg S., Kellner J.D., Marrie T.J. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre– and post seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006. Vaccine. 2009; 27 (27): 3553–3560.De Carvalho Gomes H, Muscat M, Monnet DL, Giesecke J, Lopalco PL. Use of seven valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001-2007. Euro Surveill. 2009; 14 (12).De Carvalho Gomes H, Muscat M, Monnet DL, Giesecke J, Lopalco PL. Use of seven valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001-2007. Euro Surveill. 2009; 14 (12).Lepoutre A., Varon E., Georges S., Gutmann L, Lévy-Bruhl D. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001–2006. Euro Surveill. 2008; 13 (35): 18962.Lepoutre A., Varon E., Georges S., Gutmann L, Lévy-Bruhl D. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001–2006. Euro Surveill. 2008; 13 (35): 18962.Stratchounski L.S., Kozlov R.S., Appelbaum P.C., Kretchikova O.I., Kosowska-Shick K. Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre study. Clin. Microbiol. Infect. 2006; 12 (9): 853–866.Stratchounski L.S., Kozlov R.S., Appelbaum P.C., Kretchikova O.I., Kosowska-Shick K. Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre study. Clin. Microbiol. Infect. 2006; 12 (9): 853–866.Reinert R.R., Filimonova O.Y., Al-Lahham A., Grudinina S.A., Ilina E.N., Weigel L.M., Sidorenko S.V. Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia. Antimicrob. Agents Chemother. 2008; 52 (6): 2260–2262.Reinert R.R., Filimonova O.Y., Al-Lahham A., Grudinina S.A., Ilina E.N., Weigel L.M., Sidorenko S.V. Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia. Antimicrob. Agents Chemother. 2008; 52 (6): 2260–2262.Vorobieva V., Furberg A.S., Bazhukova T. et al. Nasopharyngeal carriage of Streptococcus pneumoniae among children in the Arkhangelsk region, Russia: prevalence, population structure and antibiotic resistance. 18th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, Spain. 2008. Р. 1711.Vorobieva V., Furberg A.S., Bazhukova T. et al. Nasopharyngeal carriage of Streptococcus pneumoniae among children in the Arkhangelsk region, Russia: prevalence, population structure and antibiotic resistance. 18th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, Spain. 2008. Р. 1711.Pneumococcal conjugate vaccine for childhood immunization. WHO position paper. Weekly Epidemiological Record. 2007; 82 (12): 93–104.Pneumococcal conjugate vaccine for childhood immunization. WHO position paper. Weekly Epidemiological Record. 2007; 82 (12): 93–104.
The authors declare that there are no conflicts of interest present.